OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/28/2026
Back to search
Official data from USPTO
INDERO CRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INDERO CRO
ST13
US500000079412141Class
35, 42, 44, 45
Filing
79412141
Registration
8258151
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
05/29/2026
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
06/27/2024
Registration date
05/19/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CA
Examiner
DRUHAN, CONNOR M
Law office
O70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Indero Inc.
Representatives
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Distributorship services for others in the fields of cameras and imaging equipment for use in the field of dermatology and laboratory equipment for use in the field of clinical research; electronic data collection services for business purposes in the field of preclinical and nonclinical researchclinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; collection and compilation of information into computer databases in the field of preclinical and nonclinical researchclinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use
Class 42
Medical and scientific researchconducting clinical trials for others; Providing medical and scientific research information on the design and management of clinical trials; Scientific research in relation to the design and management of clinical trials and development of clinical trials in the fields of pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; Medical and scientific researchdesigningdeveloping protocols fororganizingconductingmonitoringmanaging clinical trials and preclinical and nonclinical research studiesresearch support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products for others; Consulting services for others in the field of medical and scientific researchclinical trials and preclinical and nonclinical research studiesresearch support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; Calibration servicesthe calibration of electronic data for the purpose of conducting clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; Electronic storage of data in the field of clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; Medical research servicesresearch assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products; Scientific research in relation to the designing and conducting of clinical trials in the fields of data management and biostatistics; Providing scientific information on the design and management of clinical trials and preclinical and nonclinical research studies; Research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices
Class 44
Medical testing services in relation to subjects in clinical trials of pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices and other therapeutic products
Class 45
Regulatory compliance consulting and advisory services in relation to pharmaceutical and biologic drugs for human and veterinary usenatural health productsmedical devices
Publications
History of USPTO decisions and trademark events.
33 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/11/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2026
PUBO
PUBLISHED FOR OPPOSITION
03/31/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2026
UNTD
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
03/05/2026
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
02/26/2026
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/26/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/25/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/20/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/20/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/20/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/20/2026
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/10/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2025
GNFR
FINAL REFUSAL E-MAILED
09/09/2025
CNFR
FINAL REFUSAL WRITTEN
09/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2025
RFNT
REFUSAL PROCESSED BY IB
03/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/18/2025
RFRR
REFUSAL PROCESSED BY MPU
02/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/07/2025
CNRT
NON-FINAL ACTION WRITTEN
01/06/2025
DOCK
ASSIGNED TO EXAMINER
12/26/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Continuous trademark protection
Get notified about every new filing that threatens INDERO CRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.